Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new research ...

Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Mohammad Ali Sheffeh, MD, from the Mayo Clinic in Rochester, Minnesota, and colleagues examined the efficacy of GLP-1 RA or SGLT-2i initiation for reducing mortality or cardiovascular events among ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British research shows.

"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...

The GLP-1 tirzepatide, the active ingredient in Eli Lilly's Mounjaro, was found to reduce the risk of heart failure by 46% among individuals with obesity, according to a study published Nov. 16 in The ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

Robert F. Kennedy Jr. would have broad power as HHS secretary to strip vaccine makers' protections against lawsuits ...